WAT · News · 20260804N

Revenue Performance and Mix

WATERS CORP /DE/ · 2026-08-04 · Importance 83 · Surprise 82 · No source text

Waters reported second-quarter 2026 revenue of $1.645 billion, up 113% year over year, with growth driven primarily by recently acquired Biosciences and Diagnostic Solutions businesses. Organic revenue was $828 million, increasing 7% as reported and 9% in constant currency. The Analytical Sciences Division delivered 8% instrument growth and double-digit chemistry consumables growth, led by low-double-digit constant-currency growth in Pharma and Applied & Academic markets. Acquired businesses also accelerated, although China-related weakness affected acquired-business performance.

Key facts

• Q2 2026 revenue increased 113% year-on-year to $1.645 billion source
• Total reported revenue of $1.645 billion surpassed the high end of the guidance range source
• Organic revenue of $828 million grew 7% as reported and 9% in constant currency source
• Analytical Sciences Division growth was led by low-double-digit growth in both Pharma and A&G end markets (constant currency) source
• Analytical Sciences Division (ASD) delivered 8% instrument growth and double-digit chemistry consumables growth source
• Waters (WAT) came out with quarterly earnings of $3.05 per share source

Impact estimates